96 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
, or otherwise, including but not limited to, misappropriation of trade secrets, fraud, embezzlement or moral turpitude,
the Executive commits
8-K
EX-10.1
sgyslyn3zi66jrr
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.1
w6nw24eifuac re6m7lm
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
D
pmyj6 qxh6z0q0bdiwl
5 Dec 22
$6.00 mm in equity / options, sold $6.00 mm, 2 investors
7:25pm
8-K
EX-10.1
f031y3y3j8xjch1e
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm